When might I consider clinical trials?

[Guest guest]

Greetings,

Examples for patients: When might I consider clinical trials?

Note: Physicians who do not participate as

investigators of clinical trials are unlikely to

discuss or refer patients to trials. Thus, we

recommend, when feasible, that patients

consult independent experts for the

purpose of considering the full range of

treatment options, including clinical trials.

o When standard therapies are not yet

curative, and I want to consider

protocols that have curative potential.

o I'm elderly or in poor health. My need

is for a therapy that has lower expected

toxicities than standard treatments.

o I have indolent lymphoma and do not

require therapy, but the need to treat

soon is anticipated. I'd like to consider

protocols of a type that have lower

expected risk, which may regress or

slow progression, which are also

unlikely to preclude benefiting from

standard therapies later on.

o I have disease that is resistant to

standard protocols. I urgently need to

consider study protocols of agents with

unique mechanisms of action.

o I need to consider studies that are

aggressive, which include allogeneic

stem cell transplantation, due to having

high-risk disease or bone marrow

failure.

We've added to the above text to our brochure:

The Urgent Need to Increase Participation in Clinical Trials.

http://www.lymphomation.org/participation.pdf

Please feel free to print and distribute.

All the best,

Karl (moderator)

Patients Against Lymphoma

www.Lymphomation.org

Patients Against Lymphoma: Evidence-based information, independent of health

industry funding. No subscriptions, fees, or registration required for it's

use; and no commercials. Just our best effort to link patients and

caregivers to reputable sources of information on lymphoma and its

treatments.